May 8, 2018 / 11:23 AM / 6 months ago

BRIEF-Amicus Therapeutics Reports Q1 Loss Per Share Of $0.28

May 8 (Reuters) - Amicus Therapeutics Inc:

* AMICUS THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE UPDATES

* Q1 LOSS PER SHARE $0.28

* Q1 REVENUE $16.7 MILLION VERSUS I/B/E/S VIEW $16.9 MILLION

* SEES FY 2018 REVENUE $75 MILLION TO $85 MILLION

* Q1 EARNINGS PER SHARE VIEW $-0.36 -- THOMSON REUTERS I/B/E/S

* REAFFIRMS FY18 REVENUE GUIDANCE OF $75M-$85M AT TOP END OF RANGE

* CONTINUES TO EXPECT FULL-YEAR 2018 NET CASH SPEND BETWEEN $230 MILLION AND $260 MILLION

* CURRENT CASH POSITION, OTHER PROCEEDS, SUFFICIENT TO FUND ONGOING FABRY AND POMPE PROGRAM OPERATIONS INTO AT LEAST 2021

* CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES $605.2 MILLION AT MARCH 31, 2018, VERSUS $358.6 MILLION AT DECEMBER 31, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below